This open-label pilot psilocybin administration study investigates the influence of psilocybin on brain function and cognitive control functions in clinically and psychiatrically healthy volunteers. Participants will undergo experimental drug administration sessions after careful screening and preparation. Participants will also have brain activity measured using electroencephalogram (EEG) also during non-invasive brain stimulation using Transcranial Magnetic Stimulation (TMS).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Acute Change in Inhibitory EEG Component Amplitudes (N45, N100) from Baseline
Timeframe: Baseline up to approximately 1.5 hours post psilocybin adminstration
Change in Mystical Experience Questionnaire (MEQ30)
Timeframe: Baseline up to to approximately 1.5 hours post psilocybin administration